The Indian Journal of Chest Diseases and Allied Sciences

Register      Login

VOLUME 65 , ISSUE 3 ( July-September, 2023 ) > List of Articles

RESEARCH ARTICLE

Comparative Evaluation of Cartridge-based Nucleic Acid Amplification Test Smear Microscopy and Conventional Culture Techniques in Laboratory Diagnosis of Tuberculosis

Saleha Naseem, Parveen Naaz, Ashok Rattan, Bharti, Ishrat

Keywords : Acid-fast bacilli smear, Cartridge-based nucleic acid amplification test, Extrapulmonary, GeneXpert MTB/RIF, Pulmonary tuberculosis

Citation Information : Naseem S, Naaz P, Rattan A, Bharti, Ishrat. Comparative Evaluation of Cartridge-based Nucleic Acid Amplification Test Smear Microscopy and Conventional Culture Techniques in Laboratory Diagnosis of Tuberculosis. Indian J Chest Dis Allied Sci 2023; 65 (3):134-138.

DOI: 10.5005/jp-journals-11007-0089

License: CC BY-NC 4.0

Published Online: 05-02-2024

Copyright Statement:  Copyright © 2023; The Author(s).


Abstract

Aim: This study compared the nucleic acid amplification assay with smear microscopy and culture to assess the sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV) in patients with suspected pulmonary and extrapulmonary tuberculosis (TB) using pulmonary and extrapulmonary samples. Methods: The information for this retrospective study was collected from the Path Kind Laboratory—a National Accreditation Board for Testing and Calibration Laboratories (NABL) accredited lab in Gurugram, Haryana, India. We evaluated 1,520 samples with suspected TB for smear microscopy, culture, and GeneXpert between January 2019 and December 2020. These samples came from the pulmonary and extrapulmonary areas. Smear microscopy and GeneXpert's diagnostic capabilities for pulmonary and extrapulmonary TB were calculated, with Mycobacterium tuberculosis (MTB) culture from pulmonary and extrapulmonary specimens serving as the gold standard. Results: This study comprised 1,520 clinical samples altogether. Of these, 624 were extrapulmonary specimens, while 896 were pulmonary samples. Overall, acid-fast bacilli (AFB) smear microscopy's sensitivity, specificity, PPV, and NPV were 83.72, 91.91, 71.38, and 95.91%, respectively. Also, GeneXpert has overall values of 96.94, 81.22, 55.42, and 99.10% for sensitivity, specificity, PPV, and NPV, respectively. Conclusion: In both pulmonary and extrapulmonary specimens, the GeneXpert assay was shown to be a quick and reliable approach for detecting M. tuberculosis. Because GeneXpert can detect M. tuberculosis and rifampicin resistance in the same 2 hours as smear microscopy and MTB culture, it offers an advantage over those methods. Clinical significance: The early detection of TB can be greatly aided by the cartridge-based nucleic acid amplification test (CBNAAT). As an important part of the National Tuberculosis Elimination Program gene experts will certainly help in the elimination of tuberculosis from India.


HTML PDF Share
  1. Caulfield AJ, Wengenack NL. Diagnosis of active tuberculosis disease: From microscopy to molecular techniques. J Clin Tuberc Other Mycobact Dis 2016;4:33–43. DOI: 10.1016/j.jctube.2016.05.005.
  2. James J, Jamuna Rani R, Sathyanarayanan V, et al. Need to reinvigorateTuberculosis research in India - A review of studies registered under clinical trial registry of India. Indian Journal of Tuberculosis. Accessed on: April 2022.
  3. Fadel HM, Jehad SK. Social stigma circumstances toward tuberculosis in Hilla City/Iraq: Community insight. Indian J Public Health Res Dev 2018;9(12):1050. DOI: 10.5958/0976-5506.2018.01988.5.
  4. Latent TB Infection and TB Disease. Centers for Disease Control and Prevention, Centers for Disease Control and Prevention. Available from: www.cdc.gov/tb/topic/basics/tbinfectiondisease.htm. Accessed on: 11 December 2020.
  5. Santos-Longhurst A. Types of Tuberculosis [Internet]. Healthline. Healthline Media; 2019. Available from: https://www.healthline.com/health/types-of-tuberculosis.
  6. Zahoor D, Farhana A, Kanth F, et al. Evaluation of smear microscopy and geneXpert for the rapid diagnosis of pulmonary and extrapulmonary tuberculosis in a tertiary care hospital in North India: A descriptive prospective study. Int J Res Med Sci 2018;6(5):1756–1760. DOI: https://doi.org/10.18203/2320-6012.ijrms20181774.
  7. Rasool G, Khan AM, Mohy-Ud-Din R, et al. Detection of Mycobacterium tuberculosis in AFB smear-negative sputum specimens through MTB culture and GeneXpert® MTB/RIF assay. Int J Immunopathol Pharmacol 2019;33:2058738419827174. DOI: 10.1177/2058738419827174.
  8. Sachdeva K, Shrivastava T. CBNAAT: A boon for early diagnosis of tuberculosis-head and neck. Indian J Otolaryngol Head Neck Surgery. 2018;70(4):572–577. DOI: 10.1007/s12070-018-1364-x.
  9. Automated Real-Time Nucleic Acid Amplification Technology for Rapid and Simultaneous Detection of Tuberculosis and Rifampicin Resistance: Xpert MTB/Rif System: Policy Statement. World Health Organization, World Health Organization. Available from: www.who.int/publications/i/item/9789241501545. Accessed on: 15 February 2017.
  10. Agrawal M, Bajaj A, Bhatia V, et al. Comparative study of GeneXpert with ZN stain and culture in samples of suspected pulmonary tuberculosis. J Clin Diagn Res 2016;10(5): DC09–DC12. DOI: 10.7860/JCDR/2016/18837.7755.
  11. Sharif N, Ahmed D, Mahmood RT, et al. Comparison of different diagnostic modalities for isolation of Mycobacterium tuberculosis among suspected tuberculous lymphadenitis patients. Brazilian J Biol 2021;83:e224311. DOI: 10.1590/1519-6984.244311.
  12. Negi SS, Khan SF, Gupta S, et al. Comparison of the conventional diagnostic modalities, Bactec culture and polymerase chain reaction test for diagnosis of tuberculosis. Indian J Med Microb 2005;23(1): 29–33. DOI: 10.4103/0255-0857.13869.
  13. William A, Yogita RA, Ravinder KA. Evaluation of Rifampicin-resistant tuberculosis in pediatric patients by GeneXpert MTB/RIF. J Microbiol Infect Dis 2021;11(02):81–87. DOI: 10.5799/jmid.951506.
  14. Sun JR, Lee SY, Perng CL, et al. Detecting Mycobacterium tuberculosis in Bactec MGIT 960 cultures by in-house IS6110-based PCR assay in routine clinical practice. J Formos Med Assoc 2009;108(2):119–125. DOI: 10.1016/S0929-6646(09)60042-5.
  15. Zhao P, Fang F, Yu Q, et al. Evaluation of BACTEC MGIT 960 system for testing susceptibility of Mycobacterium tuberculosis to first-line drugs in China. PloS One 2014;9(9):e99659. DOI: 10.1371/journal.pone.0099659.
  16. Van Rie A, Page–Shipp L, Scott L, et al. Xpert(®) MTB/RIF for point-of-care diagnosis of TB in high-HIV burden, resource-limited countries: Hype or hope? Expert Rev Mol Diagn 2010;10(7):937–946. DOI: 10.1586/erm.10.67.
  17. Steingart KR, Sohn H, Schiller I, et al. Xpert® MTB/RIF assay for pulmonary tuberculosis and rifampicin resistance in adults. Cochrane Database Syst Rev 2013(1):CD009593. DOI: 10.1002/14651858.CD009593.pub2.
  18. Arora D, Dhanashree B. Utility of smear microscopy and GeneXpert for the detection of Mycobacterium tuberculosis in clinical samples. Germs 2020;10(2):81–87. DOI: 10.18683/germs.2020.1188.
  19. Montenegro SH, Gilman RH, Sheen P, et al. Improved detection of Mycobacterium tuberculosis in Peruvian children by use of a heminested IS6110 polymerase chain reaction assay. Clin Infect Dis 2003;36(1):16–23. DOI: 10.1086/344900.
  20. Li Y, Pang Y, Zhang T, et al. Rapid diagnosis of extrapulmonary tuberculosis with Xpert Mycobacterium tuberculosis/rifampicin assay. J Med Microbiol 2017;66(7):910–914.
  21. Bharati OP, Kumar M, Sharma AK. Comparative evaluation between detection of mycobacterium tuberculosis complex in samples of extra pulmonary tuberculosis using Gene Xpert MTB/RIF assay and Ziehl-Neelsen staining in a tertiary care hospital. International Journal of Innovative Science and Research Technology 2020;5(6): 1139–1141.
  22. Bajrami R, Mulliqi G, Kurti A, et al. Comparison of GeneXpert MTB/RIF and conventional methods for the diagnosis of tuberculosis in Kosovo. J Infect Developing Countries 2016;10(04):418–422. DOI: 10.3855/jidc.7569.
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.